Navigation Links
Escalon(R) Reports Third Quarter Fiscal 2008 Results
Date:5/15/2008

of $22,576,000 compared with $31,364,000 in the prior period. Product revenue increased approximately $1,944,000, or 10%, to $22,422,000 during the nine-month period ended March 31, 2008 as compared with the same period last fiscal year. The increase was related to increases in the Vascular, Drew, Sonomed, and EMI business units.

The Company reported a net loss for the nine months ended March 31, 2008 of $(3,411,000), or $(0.53) per diluted share, compared with net income of $7,087,000, or $1.14 per diluted share, in the prior year period. Cost of goods sold totaled approximately $12,787,000, or 57% of product revenue, for the nine-month period ended March 31, 2008 as compared with $11,545,000, or 56% of product revenue, for the same period last fiscal year. Operating expenses increased approximately 3% during the nine-month period ended March 31, 2008 as compared with the same period last fiscal year.

Recap of Fiscal Third Quarter 2008

Richard J. DePiano, Chairman and Chief Executive Officer, commented, "We continue to see increased product revenue from our expanded product portfolio, as well as the benefits of plans we implemented during fiscal 2007. During the current fiscal year, we have received four FDA market clearances for new product offerings including our new VascuView(TM) Visual Ultrasound System in January 2008. These products have been well received by our customers and we expect to realize further success as we continue broadening our portfolio and bringing new products to the marketplace."

Mr. DePiano added, "Turning to our third quarter financial performance, product revenue increased by approximately $1,240,000, or 18%, compared with the same period last fiscal year. In the Drew business unit, product revenue increased $390,000, or 12%, primarily due to sales of the new D3 instrument, and increased reagent revenues generated from Drew's United Kingdom facility."

"At our Sonomed business unit, we delivered an incre
'/>"/>

SOURCE Escalon Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Escalon(R) Announces Promotion of Industry Veteran Barry Durante to President of Sonomed, Inc.
2. Escalon(R) Announces FDA 510(k) Clearance for Sonomed MASTER-VU(TM) B-Scan System
3. Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access
4. Escalon(R) Reports Second Quarter Fiscal 2008 Results
5. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
6. QMed, Inc. Reports July Medicare SNP Enrollments
7. Phlo Affiliate Reports Expanded Coverage to Oregon Border
8. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Carrington Reports Second Quarter 2007 Results
11. Avitar Reports Third Quarter Financial Results for Fiscal 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... The report expects global cell isolation and ... also provides a carefully analyzed data about the vital ... market. , Full Copy of Report @ http://bit.ly/1yUxy0T ... for cell expansion will keep witnessing growth at an ... to be driven by rapid technological advancements, government funding ...
(Date:12/24/2014)... LONDON , December 23, 2014 ... Review Algeria , out today and available for free ... the actors driving change and growth in the sector today. ... has scored notable successes has been in developing a homegrown ... 70 percent local production still remains some way off. A ...
(Date:12/22/2014)... The Center for Professional Innovation ... training across the life sciences industry, has partnered with ... to provide the organization's members with discounted classroom courses, ... the more than 350 sessions across 80 course titles. ... when registering for a public course at ...
(Date:12/22/2014)... DIEGO , Dec. 22, 2014 GenomeDx ... the Decipher Prostate Cancer Classifier, a genomic test for ... in node-negative, high-risk men managed by radical prostatectomy without ... radical prostatectomy is relatively uncommon, using tumor genomics to ... of metastatic disease is an important advance. The study ...
Breaking Biology Technology:The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3
... SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company ... announced today that the company was recently nominated for ... pediatrics. The company is among three nominated ... analysts in recognition of the development of REPEL-CV(TM) Bioresorbable ...
... , ROCKVILLE, Md., June 23 MacroGenics, Inc. announced today ... company,s Board as an independent director. Mr. Costa is ... Corporation. With more than 35 years of experience in ... valuable expertise to the MacroGenics Board. , , "We ...
... the safety and integrity of the pharmaceutical supply chain ... Inc. announced today that it has received Verified Accredited ... Boards of Pharmacy (NABP) for its Woburn, Massachusetts facility. ... Beverly facility. The NABP developed VAWD in response to ...
Cached Biology Technology:SyntheMed Receives Frost & Sullivan Health Innovation Award Nomination 2Paulo F. Costa Joins MacroGenics Board of Directors 2Paulo F. Costa Joins MacroGenics Board of Directors 3CutisPharma, Inc. Receives Verified Accreditation for Wholesale Distributors from the National Association of Boards of Pharmacy for Woburn Facility 2
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM ... Practices (GCP) audit to confirm its adherence to ... This accomplishment enables HITLAB to conduct regulated smart ... highest principles for patient safety and research quality. ... healthcare access, quality, and delivery with innovative technology," ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "Global Facial Recognition ... http://photos.prnewswire.com/prnh/20130307/600769 ... identification of individuals. Facial recognition system measures the ... nose, jaw edges, mouth, and the distance between ...
(Date:12/11/2014)... PAUL, Minn. , Dec. 10, 2014 /PRNewswire/ ... wireless physiologic monitoring, has released a new series ... needs of preclinical toxicology researchers. M series, part ... help toxicologists collect the best possible physiologic data ... Adding functional endpoints to toxicology studies ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2
... Biochemistry demonstrates that grapes are able to reduce heart ... increasing the activity of several genes responsible for antioxidant ... known natural source of antioxidants and other polyphenols, which ... observed with grape consumption. This study, funded by ...
... Brussels-BE, 2 May 2013 -- A new analysis has ... which women with oestrogen-receptor positive breast cancer are at ... and may benefit from prolonged endocrine treatment. The ... with oestrogen-receptor positive breast cancer whose cancer recurs more ...
... A Boston University School of Medicine (BUSM) study ... increase their self-compassion and ability to manage thoughts and ... Education Online , also discusses how this innovative course ... more empowered to use mind-body skills with their patients. ...
Cached Biology News:Study uncovers mechanism for how grapes reduce heart failure associated with hypertension 2Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer 2Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer 3BUSM study shows positive impact of mind-body course on well-being of medical students 2
Raised to 5-HIAA coupled to BSA with paraformaldehyde....
NuCycl DAPI Kit Application: Flow Cytometry Reactivity: Human...
Request Info...
ChIP-GLAS kit for H10K-B microarray chips. Contains ChIP kit, GLAS kit, and hybridization kit. Additional reagents are required. Please see manual for details. Contains sufficient reagent for 20 reac...
Biology Products: